Skip to content

Surface Oncology, Inc.

Categories

Biopharmaceutical

About Us

Surface is a clinical-stage immuno-oncology company focused on using its specialized knowledge of the biological pathways critical to the immunosuppressive tumor microenvironment, or the TME, for the development of next-generation cancer therapies.

Scroll To Top